{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:23:57Z","timestamp":1794435837186,"version":"4.9.1"},"reference-count":121,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.neurot.2026.e00886","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T20:21:44Z","timestamp":1780777304000},"page":"e00886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["MRGPRX2 as a novel therapeutic target in headache"],"prefix":"10.1016","volume":"23","author":[{"given":"Shiva","family":"Nematgorgani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Brandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Dussor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.neurot.2026.e00886_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/03331024241297652","article-title":"Time and headache: insights into timing processes in primary headache disorders for diagnosis, underlying pathophysiology and treatment implications","volume":"44","author":"Gonzalez-Martinez","year":"2024","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1017\/cjn.2024.300","article-title":"Disparities in the representation of sex, race and ethnicity in tension-type headache clinical trials","volume":"52","author":"Tao","year":"2025","journal-title":"Can J Neurol Sci"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00886_bib3","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200517","article-title":"Socioeconomic factors associated with migraine medication prescription at a tertiary headache center: a retrospective cohort analysis","volume":"15","author":"Nandyala","year":"2025","journal-title":"Neurol, Clin Pract"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00886_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/head.14709","article-title":"Prevalence and burden of migraine in the United States: a systematic review","volume":"64","author":"Cohen","year":"2024","journal-title":"Headache J Head Face Pain"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40122-024-00690-7","article-title":"The global burden of migraine: a 30-Year trend review and future projections by age, sex, country, and region","volume":"14","author":"Dong","year":"2025","journal-title":"Pain Ther"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib6","first-page":"1","article-title":"Headache classification committee of the international headache society (IHS) the international classification of headache disorders","volume":"38","author":"Arnold","year":"2018","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/cei\/uxab025","article-title":"Immunological findings in patients with migraine and other primary headaches: a narrative review","volume":"207","author":"Biscetti","year":"2022","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00886_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/14728214.2023.2207819","article-title":"Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials","volume":"28","author":"Silvestro","year":"2023","journal-title":"Expet Opin Emerg Drugs"},{"key":"10.1016\/j.neurot.2026.e00886_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.874193","article-title":"Dural immune cells, CGRP, and migraine","volume":"13","author":"Balcziak","year":"2022","journal-title":"Front Neurol"},{"issue":"6609","key":"10.1016\/j.neurot.2026.e00886_bib10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/384560a0","article-title":"Sensitization of meningeal sensory neurons and the origin of headaches","volume":"384","author":"Strassman","year":"1996","journal-title":"Nature"},{"issue":"1-2","key":"10.1016\/j.neurot.2026.e00886_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pain.2007.03.012","article-title":"Mast cell degranulation activates a pain pathway underlying migraine headache","volume":"130","author":"Levy","year":"2007","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00886_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1515\/revneuro-2017-0044","article-title":"Neurophysiological aspects of the trigeminal sensory system: an update","volume":"29","author":"Van der Cruyssen","year":"2018","journal-title":"Rev Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00886_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0891-0618(01)00088-6","volume":"21","author":"Samsam","year":"2001","journal-title":"J Chem Neuroanat"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s10194-021-01369-6","article-title":"Is there a causal relationship between stress and migraine? Current evidence and implications for management","volume":"22","author":"Stubberud","year":"2021","journal-title":"J Headache Pain"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00886_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11916-017-0641-9","article-title":"Sleep in patients with chronic migraine","volume":"21","author":"Yang","year":"2017","journal-title":"Curr Pain Headache Rep"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00886_bib16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/nu17040669","article-title":"Dietary patterns and migraine: insights and impact","volume":"17","author":"Tu","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.neurot.2026.e00886_bib17","series-title":"Neurogenic Inflammation and its Role in Migraine. Seminars in Immunopathology","year":"2018"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00886_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache","volume":"28","author":"Goadsby","year":"1990","journal-title":"Ann Neurol: Official J Am Neurol Ass Child Neurol Soc"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/brain\/awt369","article-title":"Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38","volume":"137","author":"Amin","year":"2014","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00886_bib20","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1526-4610.2005.05135.x","article-title":"Plasma cytokine levels in migraineurs and controls","volume":"45","author":"Perini","year":"2005","journal-title":"Headache J Head Face Pain"},{"issue":"13","key":"10.1016\/j.neurot.2026.e00886_bib21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1177\/0333102413483931","article-title":"Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients","volume":"33","author":"Tuka","year":"2013","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00886_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/14728222.2020.1724285","article-title":"Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting","volume":"24","author":"Wattiez","year":"2020","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00886_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/head.12293","article-title":"Histamine in migraine and brain","volume":"54","author":"Alstadhaug","year":"2014","journal-title":"Headache J Head Face Pain"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00886_bib24","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/0333102410368444","article-title":"Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura","volume":"30","author":"Hansen","year":"2010","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/brain\/awn307","article-title":"PACAP38 induces migraine-like attacks in patients with migraine without aura","volume":"132","author":"Schytz","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2026.e00886_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2024.111382","article-title":"The initiation of a migraine associated with a specific gene responsible for regulating immune function: hypothesis","volume":"188","author":"Arumugam","year":"2024","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ana.27205","article-title":"Distinct alterations of inflammatory biomarkers in cluster headache: a case control study","volume":"98","author":"Lund","year":"2025","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00886_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1155\/2013\/796161","article-title":"Peripheral interleukin-1\u03b2 levels are elevated in chronic tension-type headache patients","volume":"18","author":"Vedova","year":"2013","journal-title":"Pain Res Manag"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pain.2010.10.002","article-title":"Tumor necrosis factor-\u03b1 induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions","volume":"152","author":"Zhang","year":"2011","journal-title":"PAIN\u00ae"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00886_bib30","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1021\/acschembio.6b00616","article-title":"Neuropeptide-induced mast cell degranulation and characterization of signaling modulation in response to IgE conditioning","volume":"11","author":"Manning","year":"2016","journal-title":"ACS Chem Biol"},{"issue":"12","key":"10.1016\/j.neurot.2026.e00886_bib31","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1210\/endo.136.12.7588332","article-title":"Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect","volume":"136","author":"Theoharides","year":"1995","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00886_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/0333102412439354","article-title":"Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38","volume":"32","author":"Baun","year":"2012","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1468-2982.1997.1703166.x","article-title":"Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide","volume":"17","author":"Ottosson","year":"1997","journal-title":"Cephalalgia"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00886_bib34","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1097\/j.pain.0000000000001953","article-title":"Repetitive stress in mice causes migraine-like behaviors and calcitonin gene-related peptide-dependent hyperalgesic priming to a migraine trigger","volume":"161","author":"Avona","year":"2020","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00886_bib35","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1124\/jpet.107.123745","article-title":"Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators","volume":"322","author":"Zhang","year":"2007","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s10194-025-01959-8","article-title":"Revisiting substance P in migraine: a methodological approach inspired by anti-CGRP and anti-PACAP success","volume":"26","author":"Pellesi","year":"2025","journal-title":"J Headache Pain"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00886_bib37","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/ejn.15888","article-title":"Meningeal mast cell-mediated mechanisms of cholinergic system modulation in neurogenic inflammation underlying the pathophysiology of migraine","volume":"59","author":"Kilinc","year":"2024","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11916-009-0040-y","article-title":"Migraine pain, meningeal inflammation, and mast cells","volume":"13","author":"Levy","year":"2009","journal-title":"Curr Pain Headache Rep"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1526-4610.1963.hed0303086.x","article-title":"Mast cells and their active substances: their role in the pathogenesis of migraine","volume":"3","author":"Sicuteri","year":"1963","journal-title":"Headache J Head Face Pain"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00886_bib40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0304-3959(88)90012-7","article-title":"Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms","volume":"8","author":"Krabbe","year":"1980","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00886_bib41","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1468-2982.2008.01566.x","article-title":"Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid","volume":"28","author":"Sarchielli","year":"2008","journal-title":"Cephalalgia"},{"issue":"14","key":"10.1016\/j.neurot.2026.e00886_bib42","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1177\/0333102420966581","article-title":"Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine","volume":"40","author":"Kopruszinski","year":"2020","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0333102418779548","article-title":"Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in mice","volume":"39","author":"Hassler","year":"2019","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s10194-023-01574-5","article-title":"PAR2 activation in the dura causes acute behavioral responses and priming to glyceryl trinitrate in a mouse migraine model","volume":"24","author":"Mason","year":"2023","journal-title":"J Headache Pain"},{"issue":"7542","key":"10.1016\/j.neurot.2026.e00886_bib45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.neurot.2026.e00886_bib46","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202501493R","article-title":"MRGPRX2 mediates mast cell-induced endometriosis pain through the sensitization of sensory neurons via Histamine\/HRH1\/TRPV1 signaling pathway","volume":"39","author":"Mao","year":"2025","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.immuni.2023.12.012","article-title":"The MRGPR family of receptors in immunity","volume":"57","author":"Gour","year":"2024","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00886_bib48","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0092-8674(01)00483-4","article-title":"A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons","volume":"106","author":"Dong","year":"2001","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nn.3881","article-title":"Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing","volume":"18","author":"Usoskin","year":"2015","journal-title":"Nat Neurosci"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00886_bib50","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.cell.2009.11.034","article-title":"Sensory neuron-specific GPCR mrgprs are itch receptors mediating chloroquine-induced pruritus","volume":"139","author":"Liu","year":"2009","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00886_bib51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tips.2023.02.002","article-title":"The structure, function, and pharmacology of MRGPRs","volume":"44","author":"Cao","year":"2023","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib52","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaci.2016.04.051","article-title":"Roles of mas-related G protein\u2013coupled receptor X2 on mast cell\u2013mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases","volume":"138","author":"Subramanian","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"Supplement_1","key":"10.1016\/j.neurot.2026.e00886_bib53","doi-asserted-by":"crossref","first-page":"112.23","DOI":"10.4049\/jimmunol.190.Supp.112.23","article-title":"\u03b2-defensins activate human mast cells via Mas-related Gene-X2: cross-regulation by LPS (P4179)","volume":"190","author":"Subramanian","year":"2013","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00886_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2024.101391","article-title":"Mrgprb2-dependent mast cell activation plays a crucial role in acute colitis","volume":"18","author":"Van Remoortel","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00886_bib55","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2024.07.002","article-title":"Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists","volume":"154","author":"Wollam","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00886_bib56","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nchembio.2334","article-title":"In silico design of novel probes for the atypical opioid receptor MRGPRX2","volume":"13","author":"Lansu","year":"2017","journal-title":"Nat Chem Biol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11882-020-00979-5","article-title":"Mast cell-specific MRGPRX2: a key modulator of neuro-immune interaction in allergic diseases","volume":"21","author":"Thapaliya","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00886_bib58","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.bbrc.2006.08.177","article-title":"Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors","volume":"349","author":"Tatemoto","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib59","doi-asserted-by":"crossref","first-page":"L312","DOI":"10.1152\/ajplung.00005.2006","article-title":"The high-affinity IgE receptor (Fc\u03b5RI): a critical regulator of airway smooth muscle cells?","volume":"291","author":"Gounni","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00886_bib60","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/cells11060953","article-title":"MRGPRX2-mediated degranulation of human skin mast cells requires the operation of G\u03b1i, G\u03b1q, Ca++ channels, ERK1\/2 and PI3K\u2014interconnection between early and late signaling","volume":"11","author":"Wang","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00886_bib61","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/cells10051033","article-title":"Unlocking the non-ige-mediated pseudo-allergic reaction puzzle with mas-related G-protein coupled receptor member X2 (MRGPRX2)","volume":"10","author":"Kumar","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00886_bib62","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/cells8020112","article-title":"Suppression of IgE-independent degranulation of murine connective tissue-type mast cells by dexamethasone","volume":"8","author":"Yamada","year":"2019","journal-title":"Cells"},{"issue":"5573","key":"10.1016\/j.neurot.2026.e00886_bib63","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1126\/science.1071550","article-title":"G protein pathways","volume":"296","author":"Neves","year":"2002","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00886_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054811","article-title":"Activation of mast cells by neuropeptides: the role of pro-inflammatory and anti-inflammatory cytokines","volume":"24","author":"Lauritano","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainresrev.2004.11.006","article-title":"The role of mast cells in migraine pathophysiology","volume":"49","author":"Theoharides","year":"2005","journal-title":"Brain Res Rev"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s10194-020-1084-y","article-title":"Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study","volume":"21","author":"Buse","year":"2020","journal-title":"J Headache Pain"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib67","first-page":"720","article-title":"Clinical features and risk factors for irritable bowel syndrome in Migraine patients","volume":"33","author":"Li","year":"2017","journal-title":"Pakistan J Med Sci"},{"key":"10.1016\/j.neurot.2026.e00886_bib68","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trsl.2016.03.013","article-title":"Mastocytosis in adulthood and neuropsychiatric disorders","volume":"174","author":"Georgin-Lavialle","year":"2016","journal-title":"Transl Res"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00886_bib69","first-page":"508","article-title":"Association between allergic rhinitis and migraine","volume":"17","author":"Saberi","year":"2012","journal-title":"J Res Med Sci: official j Isfahan Univers Med Sci"},{"key":"10.1016\/j.neurot.2026.e00886_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2021.741135","article-title":"Association between asthma and migraine: a systematic review and meta-analysis of observational studies","volume":"2","author":"Kang","year":"2021","journal-title":"Frontiers Allergy"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib71","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/jdv.20249","article-title":"Beyond the classic players: mas-related G protein-coupled receptor member X2 role in pruritus and skin diseases","volume":"39","author":"Kumar","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib72","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/jdv.20541","article-title":"No allergy, but mast cells are involved: MRGPRX2 in chronic inflammatory skin diseases","volume":"39","author":"Metz","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.neurot.2026.e00886_bib73","unstructured":"US National Library of Medicine. A randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy and safety of EVO756 in adults with atopic dermatitis. Identifier NCT07150845. Evommune, Inc.26 th August 2025 -. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07150845."},{"key":"10.1016\/j.neurot.2026.e00886_bib74","unstructured":"US National Library of Medicine. Phase 2a, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacodynamics of EP262 in subjects with atopic dermatitis (EASE). Identifier NCT06144424. Escient Pharmaceuticals, Inc.25th October 2023 \u2013 31st July 2024. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06144424."},{"key":"10.1016\/j.neurot.2026.e00886_bib75","unstructured":"US National Library of Medicine. A randomized, double-blind, placebo controlled, dose-ranging study evaluating the efficacy and safety of EVO756 in adults with moderate to severe chronic spontaneous urticaria. Identifier NCT06873516. Evommune, Inc.20th March 2025 -. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT06873516."},{"key":"10.1016\/j.neurot.2026.e00886_bib76","unstructured":"US National Library of Medicine. Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the effects of EP262 in subjects with chronic spontaneous urticaria (CALM-CSU). Identifier NCT06077773 . Escient Pharmaceuticals, Inc.25th September 2023 - 16th January 2025 Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT06077773?tab=table."},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib77","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.neuron.2019.01.012","article-title":"A mast-cell-specific receptor mediates neurogenic inflammation and pain","volume":"101","author":"Green","year":"2019","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00886_bib78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.molmed.2010.02.004","article-title":"TRPV1 in migraine pathophysiology","volume":"16","author":"Meents","year":"2010","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.neurot.2026.e00886_bib79","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-8-66","article-title":"Expression of the transient receptor potential channels TRPV1, TRPA1 and TRPM8 in mouse trigeminal primary afferent neurons innervating the dura","volume":"8","author":"Huang","year":"2012","journal-title":"Mol Pain"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib80","article-title":"PACAP activates MRGPRX2 on meningeal mast cells to drive migraine-like pain","volume":"13","author":"Sbei","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2026.e00886_bib81","series-title":"Journal of investigative dermatology symposium proceedings","article-title":"Neurovascular and neuroimmune aspects in the pathophysiology of rosacea","year":"2011"},{"key":"10.1016\/j.neurot.2026.e00886_bib82","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fncel.2018.00294","article-title":"The effects of chronic stress on migraine relevant phenotypes in male mice","volume":"12","author":"Kaufmann","year":"2018","journal-title":"Front Cell Neurosci"},{"issue":"8","key":"10.1016\/j.neurot.2026.e00886_bib83","doi-asserted-by":"crossref","DOI":"10.1177\/03331024241277941","article-title":"Glucocorticoid signaling mediates stress-induced migraine-like behaviors in a preclinical mouse model","volume":"44","author":"Hu","year":"2024","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib84","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuron.2023.09.039","article-title":"Mast-cell-specific receptor mediates alcohol-withdrawal-associated headache in male mice","volume":"112","author":"Son","year":"2024","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib85","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s10194-024-01786-3","article-title":"PACAP38\/mast-cell-specific receptor axis mediates repetitive stress-induced headache in mice","volume":"25","author":"Son","year":"2024","journal-title":"J Headache Pain"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib86","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/sc.2015.206","article-title":"Role of neurokinin type 1 receptor in nociception at the periphery and the spinal level in the rat","volume":"54","author":"Gautam","year":"2016","journal-title":"Spinal Cord"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00886_bib87","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1468-2982.1997.1707785.x","article-title":"Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study","volume":"17","author":"Goldstein","year":"1997","journal-title":"Cephalalgia"},{"issue":"17-18","key":"10.1016\/j.neurot.2026.e00886_bib88","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.drudis.2012.05.004","article-title":"Decision-making using fMRI in clinical drug development: revisiting NK-1 receptor antagonists for pain","volume":"17","author":"Borsook","year":"2012","journal-title":"Drug Discov Today"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00886_bib89","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3390\/biomedicines13102512","article-title":"Unveiling the role of CCL3: a driver of CIPN in Colon cancer patients?","volume":"13","author":"Luzac","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib90","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2016.10.001","article-title":"Nociceptor sensory neuron\u2013immune interactions in pain and inflammation","volume":"38","author":"Pinho-Ribeiro","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1016\/j.neurot.2026.e00886_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1144614","article-title":"Peripheral CCL2 induces inflammatory pain via regulation of I h currents in small diameter DRG neurons","volume":"16","author":"Li","year":"2023","journal-title":"Front Mol Neurosci"},{"issue":"81","key":"10.1016\/j.neurot.2026.e00886_bib92","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adc9417","article-title":"A mast cell\u2013thermoregulatory neuron circuit axis regulates hypothermia in anaphylaxis","volume":"8","author":"Bao","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.neurot.2026.e00886_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1477072","article-title":"Neuronal substance P-driven MRGPRX2-dependent mast cell degranulation products differentially promote vascular permeability","volume":"15","author":"Nagamine","year":"2024","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00886_bib94","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.3390\/cells10112906","article-title":"Therapeutic potential of MRGPRX2 inhibitors on mast cells","volume":"10","author":"Ogasawara","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neurot.2026.e00886_bib95","article-title":"A role for mast cells in alcohol-induced tissue damage and remodeling","volume":"5","author":"Law","year":"2015","journal-title":"J Clin Exp Pathol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib96","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/cells13030220","article-title":"Beyond allergies\u2014Updates on the role of mas-related G-protein-coupled receptor X2 in chronic urticaria and atopic dermatitis","volume":"13","author":"Lerner","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.neurot.2026.e00886_bib97","article-title":"Pathogenesis and management of atopic dermatitis: insights into epidermal barrier dysfunction and immune mechanisms","volume":"3","author":"Baidya","year":"2025","journal-title":"Explor Asthma ; Allergy"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib98","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12016-011-8252-4","article-title":"IgE, mast cells, and eosinophils in atopic dermatitis","volume":"41","author":"Liu","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00886_bib99","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.immuni.2019.03.013","article-title":"Activation of mast-cell-expressed mas-related G-protein-coupled receptors drives non-histaminergic itch","volume":"50","author":"Meixiong","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jid.2023.06.201","article-title":"Mast cells initiate type 2 inflammation through tryptase released by MRGPRX2\/MRGPRB2 activation in atopic dermatitis","volume":"144","author":"Jia","year":"2024","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib101","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2133.2002.04803.x","article-title":"Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis","volume":"147","author":"Toyoda","year":"2002","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00886_bib102","first-page":"557","article-title":"Research in practice: substance P antagonism in chronic pruritus","volume":"12","author":"Lotts","year":"2014","journal-title":"JDDG J der Deutschen Dermatol Gesellschaft"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00886_bib103","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaci.2016.12.980","article-title":"Substance P activates Mas-related G protein\u2013coupled receptors to induce itch","volume":"140","author":"Azimi","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib104","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/biomedicines10010076","article-title":"Neurogenic inflammation: the participant in migraine and recent advancements in translational research","volume":"10","author":"Spekker","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.neurot.2026.e00886_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1406438","article-title":"MRGPRX2 antagonist GE1111 attenuated DNFB-induced atopic dermatitis in mice by reducing inflammatory cytokines and restoring skin integrity","volume":"15","author":"Wong","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurot.2026.e00886_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118371","article-title":"Identification of KMH-45, a novel MRGPRX2 inhibitor with enhanced anti-pruritic properties","volume":"190","author":"Sanjel","year":"2025","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib107","article-title":"Inhibition of mast cell degranulation in atopic dermatitis by celastrol through suppressing MRGPRX2","volume":"2023","author":"Yao","year":"2023","journal-title":"Dis Markers"},{"key":"10.1016\/j.neurot.2026.e00886_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1033794","article-title":"Inhibition of MRGPRX2 but not Fc\u03b5RI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist","volume":"13","author":"Bawazir","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00886_bib109","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaci.2022.12.805","article-title":"Novel small molecule MRGPRX2 antagonists inhibit a murine model of allergic reaction","volume":"151","author":"Kumar","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.neurot.2026.e00886_bib110","series-title":"Migraine chronification is associated with higher body mass index and elevated serum interleukin-6 levels","author":"Vuralli","year":"2023"},{"key":"10.1016\/j.neurot.2026.e00886_bib111","series-title":"Seminars in cell & developmental biology","article-title":"Mast cell secretome: soluble and vesicular components","year":"2017"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00886_bib112","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/molecules25051028","article-title":"Protective effect of genistein against compound 48\/80 induced anaphylactoid shock via inhibiting MAS related G protein-coupled receptor X2 (MRGPRX2)","volume":"25","author":"Kumar","year":"2020","journal-title":"Molecules"},{"issue":"7887","key":"10.1016\/j.neurot.2026.e00886_bib113","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41586-021-04126-6","article-title":"Structure, function and pharmacology of human itch GPCRs","volume":"600","author":"Cao","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00886_bib114","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ptr.6531","article-title":"Paeoniflorin inhibits MRGPRX2-mediated pseudo-allergic reaction via calcium signaling pathway","volume":"34","author":"Wang","year":"2020","journal-title":"Phytother Res"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00886_bib115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.anai.2025.11.008","article-title":"Emerging IgE and non-IgE targeted therapies for chronic urticaria","volume":"136","author":"Chhiba","year":"2026","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.neurot.2026.e00886_bib116","series-title":"EVO756: an oral MRGPRX2 blocker targeting mast cell-neuron signaling for chronic inflammatory diseases","author":"Jacobson","year":"2025"},{"key":"10.1016\/j.neurot.2026.e00886_bib117","series-title":"EVO756 is a novel MRGPRX2 antagonist that potently inhibits human mast cell degranulation in response to multiple agonists \u2013 a potential treatment for CSU and beyond","author":"Harden","year":"2023"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib118","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s10194-024-01750-1","article-title":"Unveiling the therapeutic potential of Dl-3-n-butylphthalide in NTG-induced migraine mouse: activating the Nrf2 pathway to alleviate oxidative stress and neuroinflammation","volume":"25","author":"Liu","year":"2024","journal-title":"J Headache Pain"},{"issue":"20","key":"10.1016\/j.neurot.2026.e00886_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.06.045","article-title":"A mast cell receptor mediates post-stroke brain inflammation via a dural-brain axis","volume":"188","author":"Kothari","year":"2025","journal-title":"Cell"},{"issue":"193","key":"10.1016\/j.neurot.2026.e00886_bib120","article-title":"Migraine and stroke: \u201cvascular\u201d comorbidity","volume":"5","author":"Guidetti","year":"2014","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00886_bib121","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-025-02209-8","article-title":"Subnanomolar MAS-related G protein-coupled receptor-X2\/B2 antagonists with efficacy in human mast cells and disease models","volume":"10","author":"Al","year":"2025","journal-title":"Signal Transduct Targeted Ther"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926000565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926000565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:17:11Z","timestamp":1783163831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926000565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":121,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1878747926000565"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00886","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRGPRX2 as a novel therapeutic target in headache","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00886"}}